Year's comments for 2013 by José Berenguer
As we approach the end of 2013, it is a good exercise for every 
microbiologist to look back and select the year’s main find-
ings and events related to microbiology, and to note the con-
tributions of the Spanish Society for Microbiology (SEM). 
The 24th Congress of the SEM was held July 10 through 13, 
at the Bellvitge Campus of the University of Barcelona, in 
L’Hospitalet de Llobregat, and on the premises of the Univer-
sity of Barcelona (Paranimph, or C e r e m o n i a l 
Main Hall) and those of the In-
stitute for Catalan Studies, in 
the center of the city (Fig. 
1). Our biennial meeting 
gathered 618 microbiolo-
gists from Spanish univer-
sities and research centers 
as well as researchers from 
24 countries. The main topics 
discussed in the Congress were 
new frontiers in research on 
the molecular basis of patho-
genicity and bacterial resistance, 
fungal virulence, antimicrobial agents 
in biodegradation and bioremediation, 
“-omic” techniques in food microbiology, 
and bacteriophages in industrial microbiology. 
Two in memoriam symposia were held, one as a trib-
ute to the American microbiologist Lynn Margulis (1938–2011) 
and the other to Miquel Regué (1953–2012), professor at the 
University of Barcelona. The dissemination of microbiology 
in society and how microbiology can take advantage of social 
networks were also discussed. [5].
The year 2013 marked the occurrence of a further rise in the 
concentration of carbon dioxide (CO2) in the Earth’s atmosphere, 
with the level reaching the symbolic record of 400 ppm (Mauna 
Loa, 10 May 2013), an amount that has not been reached in 
the last 5 to 3 million years, as far back as the Plio-
cene, when the average global temperature 
was around 4 °C higher than it is today. 
Symptoms of warming are ev-
erywhere; for example, a 
report published in 2013 
concluded that the present 
temperatures in the East-
ern Canadian Arctic are the 
highest since the beginning of 
the last ice age, 120,000 
years ago [9]. Most theo-
retical models suggest that 
global warming is today an 
unavoidable future for the 
next 50 to 100 years, and some-
how we humans will have to adapt to it 
again. There is broad consensus that only 
the use of renewable energies, rather than fossil 
fuels, will be able to reverse this process in the long term. In-
deed, several reports have discussed recent developments in 
the use of biofuels and hydrogen-producing microbes [11,14]. 
Despite the carbon dioxide increase and the present eco-
nomic crisis, significant scientific breakthroughs were made 
in 2013 that bring hope for the future of humankind. The jour-
nal Science chose cancer immunotherapy as the main scien-
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Fig, 1. Gaudi’s dragon (Python, Gaia’s son, spelled oracles, symbol of the 
communication of knowledge) at the entrance of Park Güell, Barcelona. Ar-
tistic representative of  the 24th Congress of the Spanish Society for Micro-
biology (SEM), that was held in L’Hospitalet de Llobregat and in Barcelona, 
under the presidency of Prof. Miquel Viñas.
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tific breakthrough of the year, based on the increased number 
of successful treatments. There is now hope that antibodies 
and selected T-cells can be used to treat patients with what 
previously were otherwise untreatable cancers [4]. In regen-
erative medicine, the development of in-vitro-grown organs 
and other body parts from stem cells of different kinds (livers, 
teeth, blood vessels and even rudimentary brain) constitutes 
an impressive step toward the in vitro synthesis of compatible 
organs for transplantations. Also, there were important reports 
describing successful gene therapy treatments, not only in 
animal models but also in humans with extremely disabling 
diseases [2,3].
Although apparently unrelated fields, gene therapy is only 
possible with the aid of microbiology, as it relies on the use of 
enzymes and vectors derived from microorganisms (usually 
bacteria and viruses). In fact, a major milestone in the genetic 
editing of eukaryotic genomes takes advantage of a RNA–
DNA interference system derived from the type-II CRISPR-
Cas system of Streptococcus pyogenes. This method, known 
as Cas9-edition, allows simultaneous mutations to be made in 
several genes of mammalian embryonic cells by using RNA 
oligonucleotides as guides. Cas9-edition is superior to meth-
ods based on zinc-finger nucleases and transcription activa-
tor-like effector nucleases (TALENs), and it has been imme-
diately adopted for eukaryotic genome editing by many re-
searchers throughout the world [7]. 
Two other hallmarks in human genetics and evolution re-
ported in 2013 were the completion of the sequence of a 
Nean derthal individual, from a tiny toe bone found in a cave 
in Siberia [13], and, at the end of the year, the mitochondrial 
sequence from a 400,000-year-old hominid discovered in Ata-
puerca, in northern Spain [8]. In the former, the ancient DNA 
matched that of the Denisovans, a Neanderthal-related homi-
nid whose remains were found in the same cave from which 
the Neanderthal genome was obtained. As above, the extrac-
tion and amplification of very fragmented (<50 bp) DNA is 
possible only through the use of microbial enzymes.
In the space-related sciences, the major findings of 2013 
included the discovery of hundreds of Earth-like exoplanets 
(featured in a Science special issue in May 2013) that provide 
the basis for long-dreamed habitable worlds and give strong 
support to astrobiology. Closer to the Earth, 2013 brought 
news of the success of the Curiosity rover in its journey on the 
surface of Mars (Fig. 2). Reports compiled from this micro-
laboratory with drilling capability provide lend credence to 
the hypothesis that Mars was once suitable for microbial life. 
Analysis of several Martian rocks with names such as “John 
Klein,” “Tintina,” “Sutton Inlier” (area), “Knorr,” and “Wer-
necke” in the Gale Crater revealed the presence of water, car-
bon dioxide, oxygen, sulfur dioxide, hydrogen sulfide, chloro-
methane, dichloromethane, and calcium sulfate. In addition, 
the Curiosity’s instruments provided evidence for the pres-
ence of subsurface water in amounts as high as 4 %, down to 
a depth of 60 cm, suggesting that subsurface conditions still 
harbor water and mineral sources with enough energy to sus-
tain living subterranean microbiota, such as those in the deep 
subsurface of our planet [21]. 
New frontiers of life were explored also on Earth. A group 
led by Scott O. Rogers, from Bowling Green State University, 
Ohio, published metagenomic data from the accretion ice of 
Lake Vostok, at a depth of more than 3700 m in the Antarctic 
[18]. This ice, which formed when the overlying glacial ice 
moved over the surface of the lake, contains an astonishing 
diversity of Bacteria, with minor representations of Eukarya 
and Archaea, all apparently thriving in a buried lake similar to 
the ice-covered seas of Europa and Enceladous, Jupiter and 
Saturn’s moons, respectively. Another hallmark was the find-
ing of large populations of bacteria at the bottom of the Mari-
ana Trench, the deepest part of the Earth’s surface. There were 
also reports on microbes living inside rocks buried deep be-
low the sea floor.
All of these extreme environments offer further evidence 
that microbial life requires very little in the way of nutrients to 
exist, and support the search for extraterrestrial life. Reports 
on the survival of microbes in outer space and the strong re-
minder of the effects of ancestral collisions with objects from 
space—provided by the explosion over Chelyabinsk, Russia, 
of the most significant meteor since the 1908 Tunguska event, 
in Siberia—are additional, potent arguments to study outer 
space as a major shaper of life on Earth.
Fig. 2. Rover Curiosity (NASA photograph recreation)
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Also in 2013, a relevant advancement in our understand-
ing of microbial evolution was achieved through the sequenc-
ing of the single-cell genomes of 201 uncultured Bacteria and 
Archaea [16]. In addition to being an impressive technical 
goal, the work revealed spectacular cases of lateral gene 
transfer and modifications of the genetic code, both of which 
expand our understanding of the evolution of prokaryotes 
since the origin of life on Earth. In related news, the discovery 
of some of the oldest fossils on Earth, in the Dresser sand-
stone formation in Western Australia, which has been dated 
back to almost 3500 million-years ago, was reported [10]. The 
fossils represent microbial mats and demonstrate the exis-
tence of phototrophic metabolism very early in evolution. 
In present earth-bound microbiology, the relationship be-
tween microbiota and health was a major topic in 2013. After 
the description, in 2012, of the human microbiome by an inter-
national consortium (“Human Microbiome Project”), a series 
of fascinating articles were published that related human 
health and sickness to the presence of specific microbiotal pat-
terns. Equally fascinating were reports on the effects of the 
transplantation of microbiota from healthy individuals 
(“healthy microbiota”) to those with specific disorders. Papers 
published in Science in February and September, by a group 
directed by Jeffrey I. Gordon, from Washington University, St. 
Louis, Missouri, a world leader in gut microbiome research, 
described the transfer by fecal microbiota from twins discor-
dant for obesity of obese or lean phenotypes, when the mi-
crobes were transplanted into mice [15]. These studies evi-
dence the crucial role of gut microbes in maintaining health 
independently of genetic inheritance. Another article, pub-
lished in Cell by the end of the year [6], showed that, in mice 
models, certain types of autism in animals that also have gas-
trointestinal disorders can be ameliorated by oral treatment 
with gut microbes such as Bacteroides fragilis. This unexpected 
connection between microbiota and the brain points to a puta-
tive probiotic therapy for certain types of autism.
Other major announcements in 2013 were related to the 
development of vaccines or improved treatments against ma-
jor pathogens. In HIV therapy, the news of a “cure” of a 
30-month-old child who had received antiretroviral therapy in 
the first 18 months of life [12] had a major impact in medical 
microbiology and in society. In fact, it is the first case in 
which the HIV virus has been eradicated from an infected 
infant. In addition, successful phase I clinical trials of an HIV 
vaccine offer new hopes in the fight against this devastating 
virus in developing countries, where present therapies are not 
affordable. A major step against malaria was also announced, 
when a new intravenous vaccine made of whole sporozoites 
was shown to be highly effective and safe [17]. These suc-
cesses in the fight against infectious diseases were, however, 
accompanied by disappointments, especially the failure in 
human trials of a much anticipated new vaccine against tu-
berculosis [20].
In the 2012 comments of the year, we noted the death of 
Carl Woese, who had a major influence on our concept of life, 
by defining three domains based on the analysis of 16S–18S 
RNA as a molecular clock. Nowadays, this approach is a rou-
tine tool to establish the phylogenetic relationships and tax-
onomy of every new organism isolated. In 2013, we note the 
deaths of three other important scientists who also very sig-
nificantly contributed to our understanding of how life func-
tions and evolves. On April 19, François Jacob (b. 1920) 
passed away in Paris. As co-discoverer of the mechanism un-
derlying the regulation of gene expression in bacteria (the 
“operon model”), he was a seminal figure in the development 
of modern microbiology and contributed to what became the 
Fig. 3. Christian de Duve (1917–2013), Frederick Sanger (1918–2013), and François Jacob (1920–2013).
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era of molecular biology, in the years following the publica-
tion of the structure of DNA. For this work he shared the 1965 
Nobel Prize in Physiology or Medicine with Jacques Monod 
and André Lwoff. On May 4, Christian de Duve (b. 1917) died 
at his home in Belgium. He discovered lysosomes, an essen-
tial organelle in both the structure and function of the eukary-
otic cell. He shared the 1974 Prize in Physiology or Medicine 
with Albert Claude and George E. Palade. On November 19, 
Frederick Sanger (b. 1918) died in Cambridge, UK, at the age 
of 95. Sanger was an exceptional scientist and was twice 
awarded the Nobel Prize in Chemistry, the first time (1958) 
for his work on the development of methods for sequencing 
proteins (Sanger’s method of peptide end-group analysis), 
with his groundbreaking work on the sequence of bovine in-
sulin. The second time (1980), he shared the prize with Walter 
Gilbert, for the development of a sequencing method, in this 
case for DNA. Sanger’s method was based on the use of spe-
cific dideoxy-nucleotides as DNA strand terminators by DNA 
polymerases and their subsequent separation by size. This 
method is still in use, with some modifications, and has al-
lowed the sequencing of whole genomes, including the human 
genome, and has paved the way to the present genomic era. 
The work of de Duve, Sanger, and Jacob forms a cornerstone 
in modern biology and will continue to guide and inspire all 
researchers involved in the biological sciences (Fig. 3).
 
* * *
The funding of science in Spain remains a serious problem. In 
addition to a tremendous decrease in the science budget since 
2009, the delayed publication of the National Plan for Sci-
ence, which was published in November 2013 instead of De-
cember 2012, will postpone, for at least 6 months, the starting 
period of 2014 projects. Consequently, many of the planned 
projects, involving around one third of Spanish academic 
groups, many of them highly competitive, have been left 
without funding for half a year. Some of these groups will 
have to drastically reduce their sizes and activities, with ad-
verse effects on scientific production over the next 2–3 years. 
We must denounce the short-sightedness of our politicians 
while we try to adapt to the lack of funds by concentrating and 
coordinating our research through collaborative programs, 
such as the European Horizon 2020, which has its first call in 
April 2014.
On a more positive note, on December 19th, the last day of 
parliamentary activity in Spain for the year 2013, most of the 
parliamentary groups in Madrid signed an “agreement for re-
search, development and innovation,” promoted by COSCE, 
the Federation of Spanish Scientific Societies, with which 
SEM is affiliated. The signed agreement included four points: 
the recovery, in three years, of the 2009 levels of science 
funding and a progressive increase in the percentage of the 
national budget dedicated to science to reach the mean levels 
of the EU; the elimination of the 10 % limit on incorporating 
personnel in science; the avoidance of funding delays; and the 
creation of a State Agency of Research, as originally proposed 
in 2011. Despite our prudent skepticism regarding the prom-
ises of politicians, this agreement is a step forward in that it 
considers science as a matter of state, independent of the color 
of the government in turn. This should be also the case for 
education, but the needed level of maturity among our politi-
cal parties has yet to be reached.
In the dissemination of science, the last few years have 
witnessed an increase in the number of open access publica-
tions, a process in which InternatIonal MIcrobIology is 
highly active, although the model is still a matter of contro-
versy [1]. Both the European Union, in the Horizon 2020 pro-
gram, and the Spanish National Plan for Science have explic-
itly specified that the research results of the projects they fund 
must be published in an open access format, and a specific 
budget to do so will be established. However, we are all aware 
of the high fees that major commercial scientific publishers 
charge for articles that will appear in their open access jour-
nals. Bearing in mind the decrease in public funding for sci-
ence in Spain, such fees are clearly excessive and efforts at 
more reasonable fee structuring should be encouraged. For 
journals belonging to learned societies, including Interna-
tIonal MIcrobIology, efforts are and will be made to keep 
open access publication fees as low as possible, ensuring that 
they will not be significantly more expensive than those 
charged by the printed forms of journals of reference in the 
field. In this context, I would like to call our readers attention 
to the controversy sparked by the 2013 winner of the Nobel 
Prize in Physiology or Medicine, Randy Schekman, who 
made note of the pernicious role played by what he calls “lux-
ury journals” in the evaluation of scientific quality and of the 
need for a greater number of open access journals combined 
with IF-independent criteria to properly evaluate the quality 
of the scientific work [19].
* * *
Perhaps as a reflection of our policy of keeping low publica-
tion fees combined with our commitment to maintaining high 
standards of quality, in 2013 InternatIonal MIcrobIology re-
ceived 160 manuscripts from 40 countries. Of these, 28 arti-
cles were published in four issues after being accepted by peer 
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reviewers. The diffusion of the digital version of the journal 
through the web of the Institute for Catalan Studies, our co-
editor, has increased constantly since 2011, the first year that 
the journal was available on the IEC publication’s portal; in 
2011, there were 64,108 downloads; in 2012, 101,783; and in 
2013, 173,822. The articles published in 2013 covered the 
great diversity of microbiology, from environmental biology 
and biodiversity to biodegradation and pathogenesis. From 
these pages we encourage all members of the SEM as well as 
microbiologists from Latin America to publish in Interna-
tIonal MIcrobIology.
In 2013, the four images featured as the central cover pho-
to were: a leaf-cutter ant from Costa Rica (Atta colombica) 
(March), a marsh of the Lerma River in Mexico (June), the 
Gaudi’s famous dragon in Barcelona (September), and a Chil-
ean desert landscape (December). The four micrographs (rep-
resenting viruses, bacteria, protists, and fungi) that regularly 
appear as the background of the front cover of InternatIonal 
MIcrobIology were made by microbiologists from Spain. 
One of them, from the Institute for Marine Sciences (CSIC, 
Barcelona), provided us with an image of the recently discov-
ered bacteriovorous protist Minorisa minuta, one of the small-
est eukaryotic cells known so far (1.4 µm average). Latin 
American countries have a long history of prominent re-
searchers in public health and infectious diseases, since the 
early 18th century. Continuing our tradition of promoting mi-
crobiologists pioneers from the “South”, our back covers fea-
tured the portraits of Rafael Rangel (1877–1909), the Venezu-
elan founder of parasitology and biological analytics in his 
country, in March and June, and Miguel Ángel Ugarte Vega 
(1862–1898), pioneer of medicine in Honduras, in September 
and December. 
As in previous years, on behalf of the publication and edi-
torial board, I would like to thank and recognize the efforts of 
the many researchers who voluntarily devoted part of their 
time and expertise to reviewing the manuscripts received by 
our journal. A list of their names and affiliations can be found 
on page 267 of this issue. Their work is of utmost importance 
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